The Axxent electronic brachytherapy system from Xoft of Sunnyvale, CA, is being used for the first time by Rhode Island Hospital to treat endometrial cancer.
The Providence facility is the first hospital to use the technology for that application since the U.S. Food and Drug Administration (FDA) cleared Axxent for uterine cancer treatment.
Axxent, first approved for early-stage breast cancer, uses a miniaturized x-ray source to deliver localized and targeted radiation treatment to reduce the risk of recurrence of the disease. It is inserted into the tumor through a catheter to the site, allowing medical staff to be in the room with the patient while administering treatment.
Related Reading
Xoft debuts mobile brachytherapy vehicles, September 18, 2008
Xoft launches electronic brachytherapy registry, June 26, 2008
Xoft taps new CMO, June 18, 2008
FDA clears Xoft's new applicators, May 21, 2008
Xoft medical director wins Gotham's Ira Sohn prize, April 4, 2008
Copyright © 2008 AuntMinnie.com
